Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN||042A21A / 1||LA / IM|
Administered by: Public Purchased by: ??
Symptoms: No adverse event, Interchange of vaccine products
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: No
Current Illness: No
Preexisting Conditions: Rheumatoid Arthritis
Allergies: adalimumab, dulaglutide, empaglifozin, hydrochlorothiazide
Diagnostic Lab Data: No
CDC 'Split Type':
Write-up: Client had received 2 doses of Pfizer. Client is on immunosuppresive therapy. Privary Care physiciaian recommened getting a dose of a different type of Covid-19 vaccination, recommended Janssen. client was over the 28 days recommended between types of vaccines for Covid. No adverse reactions occured at either the time of vaccination or after vaccination
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166